Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

The FDA approved a new Pfizer drug for hair loss in teens.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Biological therapy boosts the immune system to effectively fight melanoma.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

JAK inhibitors can enter the skin through hair follicles using a unique pathway.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.